Transition from Intravenous Epoprostenol to Intravenous Treprostinil in a Portopulmonary Hypertension Patient with Thrombocytopenia

被引：0
|
作者：
Kusumoto, Mie [1 ]
Araki, Masaru [1 ]
Nagata, Yasufumi [1 ]
Hayashi, Atsushi [1 ]
Tsuda, Yuki [1 ]
Otsuji, Yutaka [1 ]
机构：
[1] Univ Occupat & Environm Hlth, Japan Sch Med, Dept Interal Med 2, Fukuoka, Japan
来源：
JOURNAL OF CARDIAC FAILURE | 2015年 / 21卷 / 10期
关键词：
D O I：
10.1016/j.cardfail.2015.08.239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP34-5
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 50 条
  • [1] Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension
    Gomberg-Maitland, M
    Tapson, VF
    Benza, RL
    McLaughlin, VV
    Krichman, A
    Widlitz, AC
    Barst, RJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (12) : 1586 - 1589
  • [2] case series: thrombocytopenia improvement with transition of intravenous epoprostenol to intravenous treprostinil
    Kooda, Kirstin
    Armon, Jeff
    Ou, Narith
    [J]. PHARMACOTHERAPY, 2017, 37 (12): : E227 - E228
  • [3] Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil
    Ivy, D. Dunbar
    Claussen, Lori
    Doran, Aimee
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (05): : 696 - 698
  • [4] Multicenter experience with the rapid transition to intravenous treprostinil from epoprostenol in pulmonary arterial hypertension
    Shapiro, Shelley
    Waxman, Aaron
    Schilz, Robert
    Strootman, Deb
    Rollins, Kristan
    Feldman, B. Jeremy
    [J]. CHEST, 2007, 132 (04) : 635S - 635S
  • [5] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
  • [6] Chronic intravenous infusion of epoprostenol reverses portopulmonary hypertension
    Kuo, PC
    Johnson, LB
    Plotkin, JS
    Njoku, M
    Howell, CD
    Bartlett, ST
    Rubin, LJ
    [J]. HEPATOLOGY, 1996, 24 (04) : 1210 - 1210
  • [7] Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension
    Kuo, PC
    Johnson, LB
    Plotkin, JS
    Howell, CD
    Bartlett, ST
    Rubin, LJ
    [J]. TRANSPLANTATION, 1997, 63 (04) : 604 - 606
  • [8] Transition protocol from subcutaneous treprostinil to intravenous epoprostenol in deteriorating patients with pulmonary arterial hypertension
    Mouratoglou, Sophia Anastasia
    Patsiala, Anthoula
    Feloukidis, Christos
    Karvounis, Haralambos
    Giannakoulas, George
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 187 - 189
  • [9] Transition from Intravenous Epoprostenol to Treprostinil Due to Intolerable Side Effects in Patients With Pulmonary Arterial Hypertension
    Kikuchi, Hanako
    Goda, Ayumi
    Takeuchi, Kaori
    Inami, Takumi
    Kohno, Takashi
    Soejima, Kyoko
    Satoh, Toru
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2023, 206 : 31 - 34
  • [10] Conversion From Intravenous Epoprostenol Products To Inhaled Treprostinil For Pulmonary Arterial Hypertension
    Alnuaimat, H.
    Reardon, N. T.
    Cash, J. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
12345